The growing rate of unplanned pregnancies vis-à-vis Intrauterine Contraceptive Devices – an effective contraceptive method boosts the demand for Intrauterine Contraceptive Devices market in North America

Intrauterine device (IUCD) is a small contraceptive device that is inserted into the uterus to prevent pregnancy. The IUCDs are available in two types: the copper and hormonal IUCD. The hormonal IUCD contains progesterone, which is a synthetic version of the naturally occurring hormone progesterone. Both these types are very effective methods of contraception and can stay in place for an average of at leastfive years. Key Players in the North American Intrauterine Contraceptive Devices are Bayer HealthCare AG (A subsidiary of BAYER AG) (Germany), Teva Pharmaceuticals Industries Ltd. (Israel), Actavis Plc. (Ireland), and medicines360 (Ireland).

The major drivers behind the growing intrauterine contraceptive devices market in North America include increasing rate of unplanned pregnancies, effective contraceptive method,and less side effects as compared to other contraceptive methods. In the U.S, 82.0% of the adolescent pregnancies are unplanned, accounting for one-fifth of all unintended pregnancies. The users, especially adolescents trust the intrauterine devices market, as it is extremely reliable and effective. As a result, long-acting reversible contraception (LARC) methods, such as intrauterine contraceptive devices are adopted on a large scale.

Speak to Analyst @

http://www.micromarketmonitor.com/contact/9914049840-speak_to_analyst.html

The U.S. contribution to the intrauterine contraceptive devices market in North America is 93%, as of 2014.In the U.S, under the Affordable Care Act (ACA), birth control and some other preventive services are offered without co-payments or deductibles.Also, many private firms are focusing on reducing unintended pregnancies and abortion related expenses; besides, the government also provides grants for IUCD products in order to encourage the usage of intrauterine contraceptive devices.

IUCD is safe and more effective than other contraceptives, such as oral contraceptives, as the other contraceptives have several side effects, such as dizziness, headache, lightheadedness, stomach upset, bloating, or nausea.

This market is segmented and forecast on the basis of different type and products. There are two major types of IUCDs, namely copper and hormonal IUCD. The marketed products in the purview of this report are: Mirena, Skyla, Paragard, Essure and pipeline product Livosert. The market is further segmented and forecast on the basis of major countries, such as the U.S., and Canada.

This report also includes the market share, value chain analyses, usage percentage and sales of different products, market metrics such as drivers, restraints and also the upcoming opportunities in the market. In addition, it presents a competitive landscape and company profiles of the key players in the market.

Request customization on this report.

http://www.micromarketmonitor.com/contact/9914049840-request_for_customization.html